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Abstract
DNA is the most stable nucleic acid and most important store of genetic information. DNA sequences are conserved in
virtually all the cells of a multicellular organism. To analyze the sequences of various individuals with distinct pathological
disorders, DNA is routinely isolated from blood, independently of the tissue that is the target of the disease. This approach
has proven useful for the identification of familial diseases where mutations are present in parental germinal cells. With the
capacity to compare DNA sequences from distinct tissues or cells, present technology can be used to study whether DNA
sequences in tissues are invariant. Here we explored the presence of specific SNVs (Single Nucleotide Variations) in various
tissues of the same individual. We tested for the presence of tissue-specific exonic SNVs, taking blood exome as a control.
We analyzed the chromosomal location of these SNVs. The number of SNVs per chromosome was found not to depend on
chromosome length, but mainly on the number of protein-coding genes per chromosome. Although similar but not
identical patterns of chromosomal distribution of tissue-specific SNVs were found, clear differences were detected. This
observation supports the notion that each tissue has a specific SNV exome signature.
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Introduction
Typical research and diagnostic practices analyze DNA from a
single tissue, commonly blood. Although it has been proposed that
DNA sequences show invariability [1], errors may occur in DNA
processing during development, resulting in DNA sequence
variants that spread to cellular lineages. The development of a
human being starts from the zygote and goes on to form an
organism with 1013 to 1014 cells [2]. During this process, a number
of somatic mutations may take place, mainly caused by errors in
DNA replication or reparation that primarily occur during cell
proliferation. Once the adult organism has been formed, cell
proliferation from adult stem cells may lead to the appearance of
somatic mutations during adulthood, thus resulting in the
formation of genetic mosaicism. In addition, somatic genomic
variability may include cell lineages in various tissues [3,4].
Accordingly, a number of DNA variations may arise during early
embryonic periods, later developmental phases, or during
adulthood, with their frequency and location being determined
by when and where they were formed.
The cell populations of tissues differ, and a given population
may show a specific SNV in its DNA. Thus, the identification of
variants in a small cell population in a specific tissue calls for a
DNA sequencing method with high sensitivity [5]. Sequencing
DNA samples by the Sanger method is a useful and reliable
approach for the detection of sequence variations, but it is
designed to analyze homogeneous samples. Consequently, in a
small proportion of isolated DNA of the cell population of interest,
the method is not sensitive enough to detect a SNV. Moreover,
this variant may not be distinguishable from signal noise in
chromatograms.
Several types of variation may arise, like missense and nonsense
base substitutions (SNV), deletions, and insertions, or variations
caused by other mechanisms, such as the movement of transport-
able elements [6,7]. Also, the likelihood of a variation in DNA
sequence may differ depending on the cell origin. Indeed, some
cells may be more sensitive to DNA damage than others.
Furthermore, not all the bases in the human genome are equally
prone to chance mutations [8]. Also, chromosome distribution
inside the cell may influence the occurrence of tissue-specific
exonic SNVs and their distribution in chromosomes.
Here we studied the presence and distribution of SNVs along
chromosomes, with a special emphasis on the number of tissue-
specific exonic SNVs and their location. We detected a particular
distribution of exonic SNVs that appears to be related mainly to
the number of protein-coding genes in each chromosome. We also
identified tissue-specific SNVs (comparing tissue by tissue) whose
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distribution along the chromosomes differed in function of the
tissue studied. Moreover, we observed that certain tissues have a
similar pattern of SNV distribution in some chromosomes,
correlating with their embryonic origin. This observation would
support the notion of a common embryonic origin.
Materials and Methods
Nomenclature
The term single nucleotide variation (SNV) is used to define a
variation in a single nucleotide that occurs in the genome, while
the more specific term single nucleotide polymorphism (SNP) is
understood to be a single nucleotide variation that arises at
appreciable frequency (at least 1%) in the population [9]. The
term tissue-specific SNV is used to define a variation found only in
one of the samples analyzed when these are compared pairwise,
but it could be shared with other tissues.
Ethical statement
Samples from donors A and B, were obtained from the Spanish
Brain Bank (Banco de Tejidos CIEN [BT-CIEN], http://bt.
fundacioncien.es/) and samples from donor C were obtained
from the Biobanco del Sistema Sanitario Pu´blico de Andalucı´a (http://
www.juntadeandalucia.es/salud/biobanco/). Donors gave their
written informed consent and the tissues were obtained using
protocols approved by the ethical committee of the Spanish Brain
Bank and the Biobanco del Sistema Sanitario Pu´blico de Andalucı´a. Our
work was previously approved by the ethical committee of our
center (Comite´ de E´tica de la Investigacio´n conjunto CNB-CBMSO,
http://www.cnb.csic.es/,cei/).
Origin of human samples and characteristics of donors
Blood and hippocampus samples were obtained from patients A
and B, and samples of the following were obtained from patient C:
adipose tissue, blood, frontal cortex, kidney, liver, lung, motor
cortex, lung, skeletal muscle, skin, small intestine, spinal cord,
spleen, suprarenal cortex, and testis. The characteristics of the
donors are described in Table 1.
Subject A suffered from diabetes, and had surgery for prostate
and cataract.
Subject B suffered from an amyopatic dermatomyositis with
rapidly progressing interstitial lung disease. During the last phase
of his disease the patient received ceftriaxone, fluconazole,
meropenem, voriconazole and linezolid.
Subject C suffered from multifocal and bilateral enphysema,
dilated myocardiopathy and atherosclerosis.
Tissue sample preparation
Post mortem tissues were obtained through a rapid pathological
autopsy shortly after death. The post mortem interval was 3 hours.
According to the protocol, immediately after the autopsy the fresh
tissues were flash-frozen in 250uC isopentane. Thereafter each
frozen tissue was introduced in a 280uC freezer for long-term
preservation. Specific frozen tissue samples of various brain
regions were obtained from the corresponding slices after a
2 hour period of temperature soothing. Each sample was obtained
with the aid of sterile disposable material and introduced in sterile
cryo-tubes. Thereafter the samples were kept at 280uC. The rest
of tissues were obtained and frozen with similar protocols. Blood
samples were obtained simultaneously with routine blood extrac-
tions.
DNA isolation
All genomic DNA samples were isolated from blood and the rest
of the tissues using Qiagen kits (DNeasy Blood and Tissue,
ref:69504), according to the manufacturer instructions.
Sample processing for exome sequencing. 361026 g of
genomic DNA was fragmented to an average size of 200 bp using
a Covaris LE220 instrument. Short insert libraries were obtained
using the Illumina TruSeq DNA Sample Preparation Kit. Exonic
sequences were enriched using NimbleGen Sequence Capture
Human Exome 2.1 M Array. Paired-end sequences of 91
nucleotides from each end were generated using an Illumina
HiSeq 2000 instrument to an average of 506coverage. Sequences
were generated in fastaq format.
Table 1. Characteristics of subjects studied.
Subject Gender Age Cause of Death Other known diseases
A M 84 Pneumonia Diabetes Prostatic hyperplasia
B M 46 Pneumonia Intersticial fibrosis
C M 66 Pneumonia Enphysema Myocardiopathy Atherosclerosis
doi:10.1371/journal.pone.0101412.t001
Figure 1. SNVs found in blood for individuals A and B. a)
Scheme showing how flanking intronic sequences can be detected in
exome sequencing. The capture of exonic reads includes intron regions
at both ends of the exons. b) Total number of SNVs found in blood from
subjects A and B. The annotation software of SNVs (see materials and
methods) classified these variations as exonic and non-exonic. For the
aims of this work, we considered only exonic variations.
doi:10.1371/journal.pone.0101412.g001
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Bioinformatics analysis. Samples were aligned to the
human reference genome version hg19 [10] using the BWA
aligner software [11] with default parameters. For each patient, all
the samples were pre-processed using Picard software to remove
duplicate reads (http://picard.sourceforge.net/). Local realign-
ment was performed around indels to improve SNV calling in
these conflictive areas (IndelRealigner from the Genome Analyzer
Toolkit, GATK, version 2.1-8 [12]). Base quality scores were
recalibrated using BaseRecalibrator from GATK. The Unified-
Genotyper algorithm from GATK was then used with default
parameters (see [13,14] for details) to call SNVs, and a first file
including raw calls was obtained. We then separated the indels
from the rest of the calls and only Single Nucleotide Variations
(SNVs) were considered for the analysis. These variants were
filtrated with VariantFiltration, from GATK, using the following
parameters: coverage: DP .10, DP .20, DP.50 or DP .100,
depending on the case of study; QD ,2.0; FS .60.0, MQ ,35.0;
HaplotypeScore .13.0; MQRankSum ,212.5 and ReadPos-
RankSum ,28.0. We selected only calls that passed these filters.
Variants were annotated using the dbSNP database version 135
[15], the UCSC human RefGene [16], and the software snpEFF
(version 2_0_5) [17]. In order to manipulate the files containing
variations and to determine how many of these variations were
unique or common to different tissues, we used the software
VCFtools [18]. All analyses to determine enrichments in Gene
Ontologies (GOs) based on gene lists were performed using the
web-based tool GeneCodis [19].
Results
Similar number of SNVs in blood DNA from two different
subjects
As a first step, we performed exome sequencing of blood DNA
from two different subjects. This procedure was performed
considering a range of read depths (10 to 100). When a low read
depth (10 reads) was used, a difference of about 0.1% in the SNVs
of the genomic sequences of the two subjects was observed. This
difference was attributed to SNVs and was in the order of the
expected data [8]. Nevertheless, to achieve a deeper coverage, for
the rest of the experiments we considered only SNVs observed in
at least 20 reads. More than 98% of the SNVs obtained for each
sample were found in dbSNP [15]. Below we also comment on the
results obtained for 50 and 100 reads.
Although exonic sequences were enriched (see methods), non-
exonic ones located at both ends of exons were also mapped (see
Figure 1a). Figure 1b shows the appearance of intronic and exonic
SNVs. However, for the rest of the study we focused on the latter.
Due to the differences in age of the two subjects (A and B), we can
not rule out that some of the observed differences between those
persons could be based in that differences of age. However, as
indicated in the figure 1b the number of SNV are very similar in
both individuals, which would suggest that most SNVs arise from
differences during development.
To test whether the number of SNVs in a specific chromosome
correlates with chromosome length or number of exons present,
we calculated the number of SNVs in each chromosome. No clear
relationship between the number of SNVs per chromosome and
chromosome size in Mb was detected (Figure 2a).
Figure 2b points to possible link between the percentage of
exons (with respect to total exons in genome [20]) per
chromosome and the percentage of SNVs (with respect to total
exonic SNVs found in each sample) for each chromosome.
However, some exceptions were detected, mainly for chromo-
somes 2, 11 and 19, for which the percentage of SNVs was higher
than that of exons. In other cases, like chromosomes 7 and X, the
percentage of SNVs was lower than would be expected. Moreover,
a better correlation in the number of SNVs per chromosome was
appreciated when these were compared with the percentage of
protein-coding genes in each case (according to the data obtained
from Ensembl [21]) (Figure 2c). For chromosome X, there was an
obvious difference between the number of protein-coding genes
and the SNVs found in these conditions. This observation is
consistent with the genetic diversity of chromosome X being lower
than that of autosomes [22].
Similar number and chromosomal distribution of SNVs
but different chromosomal distribution of hippocampus
and blood-specific SNVs
To reveal possible differences in chromosomal distribution of
SNVs in DNA sequences from two types of tissue from the same
individual, we analyzed and compared the distribution of SNVs
along all the chromosomes in exonic sequences in the hippocam-
pus (Figure 3a) in individuals A and B. The number of
hippocampal SNVs was found to be similar to that found in
blood (see Figure 1A).
Figure 3b shows the total number of blood-specific SNVs (SNVs
present in blood but not in the hippocampus of the same
individual) and hippocampus-specific SNVs (present in the
hippocampus but not in blood) for individuals A and B.
The screening of hippocampus- and blood-specific SNVs in all
the chromosomes (Figure 3c) revealed that these variations did not
occur in a random manner.
Presence of a specific SNP at a given time when the
exome was subjected to 20, 50 and 100 reads.
Interpretation of the data
Sequence analyses were done using 361026 g of DNA per
sample. Assuming that each diploid male somatic cell in G1 phase
of the cell cycle holds 6.4610212 g DNA [23], we can say that in
ideal conditions we would have (361026 g of DNA sample/
6.4610212 g DNA by cell) .56105 cells per sample. Thus taking
one DNA molecule, assuming all the cells in the sample to be
identical, there would be 56105 identical DNA molecules of this
type in the sample. However, if the sample contained more than
one cellular type and only some of these cells had SNVs, there
Figure 2. Number and distribution along the chromosomes of blood exonic SNVs. a) Total number of exonic SNVs found in blood for each
chromosome for subjects A and B. The chromosomes are sorted by size in Megabases from low to high. No correlation is appreciated between the
length of the chromosome and the number of SNVs found in each case. b) White bars represent the percentage of SNVs per chromosome with
respect to the total SNVs found in blood for subjects A and B. Gray bars indicate the percentage of exons (with respect to the number of total exons
in the human genome [21]) for each chromosome. Bars were sorted in this case from lower to higher number of exons/chromosome. There seems to
be a certain correlation between the number of exons and the number of SNVs per chromosome, with some exceptions, mainly for chromosomes 7,
2, 11, 19 and X. Error bars indicate the standard deviation of the measurements. c) As in b), white bars show the average of the percentage of total
SNVs in each chromosome for subjects A and B, but in this case gray bars indicate the percentage of protein-coding genes with respect to the total
number in the human genome[21]. Bars were sorted from lower to higher number of protein-coding genes/chromosome. Error bars indicate the
standard deviation of the measurements.
doi:10.1371/journal.pone.0101412.g002
Tissue-Specific Single Nucleotide Variants
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Figure 3. Number and distribution along the chromosomes of hippocampal- and blood-specific SNVs for individuals A and B. a)
Chart showing the total number of exonic SNVs found in the hippocampus for each chromosome for subjects A and B. The chromosomes are sorted
by size in Megabases from low to high. b) Chart showing the number of unique SNVs found in blood for subjects A and B with respect to
hippocampus (white bars) and in hippocampus with respect to blood (black bars) for the same subjects. This number was obtained with a coverage
of at least 20 reads per SNV (see methods). c) Distribution of the percentage (respect to total of SNVs) of unique SNVs present in chromosomes in
blood for subjects A and B but not in hippocampus (dashed line, Bl_Hi) or in hippocampus but not in blood (continuous line, Hi_Bl).
doi:10.1371/journal.pone.0101412.g003
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would be differences among the sequences of various types of cell,
and the proportion of sequences containing these SNVs would
correlate with the proportion of these cells in the whole tissue. If
the variation were already in the germline, all the cells, regardless
of their type, would have that SNV. Also, if the variation had
taken place during development or early in life, the number of cells
with that SNV would be higher than if the variation had occurred
later during adulthood.
An estimate of the percentage of cells bearing a specific SNV
can be inferred from the percentage of reads bearing that
particular variation.
Figure 4a (inset) compares the number of hippocampus-specific
SNVs found in individuals A and B in function of the number of
times the SNVs were read, 20 (DP20), 50 (DP50) or 100 (DP100).
As expected, the number of SNVs decreased as the reads increased
due to the heterogeneity of the sample. The high coverage of these
SNVs was probably caused by the greater number of copies of the
sequences containing these SNVs, these variants were probably
formed early in development and they spread to their cellular
lineage than those SNVs present after reading the sample 20 times.
SNVs sequenced after 100 reads could be validated by other
sequencing techniques. Although we consider it difficult to validate
SNVs detected only at lower reads, these variations may also be
relevant because they may have arisen from changes occurring in
late development.
SNVs in tissue types are present in loci related to the
physiology of the tissue
The presence of tissue-specific SNVs in a cell type could be
caused by errors in DNA replication or reparation that occur
during cell proliferation. When one of these SNVs is formed, it is
spread to its cellular lineage. We thus postulated that some of these
SNVs, originated early in development, may be common to many
cells in the same tissue/organ.
Here we focused on the nature of the genes containing tissue-
specific SNVs. We analyzed the molecular function of genes
carrying these tissue-specific SNVs and selected only those genes
in subjects A and B with SNVs with a coverage of 100 or more
reads. We followed this strategy in order to select the SNVs that
presumably originated earlier in the development. Two sets of
Figure 4. GO terms for genes with highly covered tissue-specific SNVs. a) (Inset) Number of hippocampus-specific SNVs (present in
hippocampus, but not in blood) for subjects A and B, taking account the number of reads covering each SNV: at least 20 (DP20), 50 or more (DP50),
and 100 or more (DP100). b) Analysis of GO terms for genes with highly covered SNVs. We selected lists of genes common to subjects A and B with at
least one SNV in hippocampus and blood, covered by at least 100 reads, in order to test for differences in the annotations of the GOs of genes with
SNVs tissue-specific. The genes with SNVs in hippocampus and blood covered by at least 100 reads were analyzed by examining genes exclusive to
the hippocampus and those exclusive to blood. The annotations for molecular function GOs overrepresented in each list of hippocampus- (left) and
blood- (right) specific genes are shown. Observe that the main annotations vary greatly for each tissue. There is overrepresentation of genes with
SNVs in the hippocampus with functions of receptor activity (21.6%), ion channel activity (13.5%) and microtubule motor activity (5.4%), while for
genes with highly covered SNVs in blood, the main molecular function annotations are GTPase activity (10.35%), Helicase activity (10.35%), and
others.
doi:10.1371/journal.pone.0101412.g004
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genes with SNVs were formed: those common to the hippocampus
(A and B samples), and those common to blood (A and B samples).
Afterwards, we compared these two sets of genes and selected the
genes bearing SNVs that were blood- or hippocampus-specific.
The selected lists of genes were analyzed using a web-based
software (GeneCodis [19]) to determine molecular functions that
are significantly linked to genes of the lists. The GO terms
obtained from the two lists differed greatly. For the genes with
hippocampal SNVs, the software determined a significant
enrichment in GO molecular functions including ‘‘receptor
Figure 5. Pairwise comparison of tissue-specific SNVs. Tissue-specific SNVs from 16 tissues from subject C: Frontal Cortex (FC), Motor Cortex
(MC), Spinal Cord (SC), Skin (Sk), Adipose Tissue (AT), Blood (Bl), Liver (Li), Skeletal Muscle (SM), Lung (Lu), Kidney (Ki), Suprarrenal Cortex (SC), Small
Intestine (Si), Spleen (Sp), Pancreas (Pa) and Thyroid (Th). Each chart shows the number of unique SNVs found exclusively in each tissue. For example,
for the Frontal Cortex, the black bars (FC_*) indicate the number of SNVs exclusive to this tissue with respect to Spinal Cord (SC), Small Intestine (SI)
… etc; and white bars (*_FC) show the number of SNVs exclusive to the tissues with respect to the Frontal Cortex in each case. The bars were sorted
from lower to higher in function of the results with respect to the white bars.
doi:10.1371/journal.pone.0101412.g005
Tissue-Specific Single Nucleotide Variants
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activity’’, ‘‘ion channel activity’’ and ‘‘microtubule motor activity’’,
among others that could be related to neuronal activity. In
contrast, for the blood SNVs, the functions determined were
completely different (‘‘GTPase activity’’, ‘‘helicase activity’’,
‘‘amino acid transmembrane activity’’, ‘‘water transporter activ-
ity’’, etc).
Exonic DNA from different tissue types bears specific
SNVs
We performed exome sequencing of 16 tissues from the same
individual (person C): adipose tissue (AT), blood (Bl), frontal cortex
(FC), skin (Sk), testis (Te), skeletal muscle (SM), small intestine (SI),
suprarrenal cortex (SC), spleen (Sp), pancreas (Pa), liver (Li),
kidney (Ki), thyroid (Th), lung (Lu), spinal cord (SC), motor cortex
(MC) and frontal cortex (FC) (Table 2). In this analysis, each tissue
was compared pairwise with the rest of tissues at a depth of 20
reads per SNV (all these SNVs are supplied in file S1). Again,
blood DNA was taken as a control (Figure 5). We found 14,446
SNVs common to all the tissues, including blood. These common
SNVs may have been inherited, formed in the zygote or early in
development. In addition, using pairwise comparison with the
other tissues, a relative high number of SNVs were found to be
present exclusively in blood DNA, thus raising the possibility that
blood DNA is not an optimal tissue for genomic studies since it
bears the largest number of somatic SNVs in adults.
Figure 5 also shows the presence of SNVs in a specific tissue
(frontal cortex) that were not present in another (e.g., spinal cord).
In addition, some SNVs were found in the spinal cord, but were
absent in the frontal cortex. When this procedure was repeated by
pairwise comparison in all the tissues, unique SNVs differed from
tissue to tissue. Also, we found that these SNVs showed a tissue-
specific distribution along the chromosomes. Figures S1-S6 show
the distribution of tissue-specific SNVs and their position along the
chromosomes when the frontal cortex was compared with three
tissues of distinct embryonic origin: frontal cortex-spinal cord
(Figure S1), frontal cortex-blood (Figure S3), and frontal cortex-
pancreas (Figure S5). The figure also shows the distribution of the
tissue-specific SNVs found when these three tissues were
compared with the frontal cortex: spinal cord-frontal cortex
(Figure S2), blood-frontal cortex (Figure S4) and pancreas-frontal
cortex (Figure S6).
These findings suggest that some SNVs are tissue-specific in the
same subject. We thus believe that while most SNVs are already
present in germinal cells and are thus carried in every cell of the
organism, others may originate during development (thus being
shared by tissues of similar origin: ectoderm, mesoderm, endo-
derm) (Table 2). Finally, other SNVs might arise from somatic
variations during adulthood and therefore they are present
exclusively in a particular tissue.
Number of total exonic SNVs along the chromosomes in
different tissue types compared with those in blood DNA
The presence of tissue-specific SNVs in the same individual
implies a certain degree of genome heterogeneity, some of which
may arise during development. Accordingly, the genetic variability
between two tissues in the same subject would be higher or lower
depending on whether they share the same embryonic origin. In
order to test this hypothesis, we undertook a first approach by
comparing the number of exonic SNVs per chromosome in blood
DNA (mesoderm origin) against: spinal cord (ectoderm), kidney
(mesoderm) and small intestine (endoderm). We detected simili-
tude in the number of SNVs along the chromosomes in tissues of
the same embryonic origin (blood and kidney, Figure 6b),
compared with those of spinal cord and small intestine
(Figure 6c, ectoderm and endoderm, respectively), and blood
and spinal cord (endoderm and ectoderm, respectively). Major
differences in the number of SNVs consistently appeared in certain
chromosomes, especially in chromosomes 19, 17 and 16.
Otherwise, as we suggested previously, the presence of SNVs in
the same genes and tissues of different people could indicate that
certain chromosomal locations are more susceptible to variations
than others. The presence of many variations in certain
chromosomes in the same individual supports this idea.
Table 2. The tissues from subject C studied and their embryonic origin.
Tissue Abreviation Embryonic layer origin
Adipose Tissue AT ectoderm
Blood Bl mesoderm
Frontal cortex FC ectoderm
Kidney Ki mesoderm
Liver Li endoderm
Lung Lu mesoderm
Motor Cortex MC ectoderm
Pancreas Pa endoderm
Skeletal Muscle SM mesoderm
Skin Sk ectoderm
Small Intestine SI endoderm
Spinal Cord SC ectoderm
Spleen Sp mesoderm
Suprarrenal Cortex SC mesoderm
Testes Te mesoderm
Thyroid Th endoderm
doi:10.1371/journal.pone.0101412.t002
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Conclusions
Blood is a highly accessible tissue that can be collected in a non-
invasive manner for the purposes of genetic analysis. Such analyses
have shown that there is about 0.1% of inter-individual variation
in sequences, which is caused by germinal and somatic mutations.
Here we analyzed the number and distribution of SNVs in blood
exonic sequences of two subjects using the Illumina method. A
difference of about 0.1% in the SNVs of the genomic sequences of
two subjects was found. Our results also revealed a similar number
of total exonic SNVs for the two subjects, as well as a similar SNV
distribution along chromosomes. The distribution of SNVs per
chromosome did not appear to be determined by chromosome size
or by the number of exons, but correlated well—with some
exceptions—with the number of protein-coding genes present in
the chromosomes. This observation supports the notion of a
relationship between gene expression and SNV number. Com-
parison of tissues other than blood, like the hippocampus, showed
the presence of tissue-specific variations. These SNVs were
Figure 6. Number of total exonic SNVs found for each chromosome in tissues from subject C compared with blood. a) Exonic SNVs
per chromosome found in a representative tissue of ectoderm origin, namely the spinal cord (SC), compared with those of blood (Bl). b) As in a) total
blood exonic SNVs per chromosome are shown, but in this case they are compared with the number of SNVs present in a representative tissue of
mesoderm origin, namely the kidney (Ki). c) Representation of the number of total exonic SNVs per chromosome found in a representative tissue of
endoderm origin, namely small intestine (SI), compared with those of blood (Bl).
doi:10.1371/journal.pone.0101412.g006
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distributed along the chromosomes in a similar but different
pattern to those found in blood. For every tissue studied, appears
to be a common pattern in the distribution along the chromo-
somes of the number of SNVs, being: chr1-chr11-chr19, chr2 the
list of sorted chromosomes with most SNVs (from high to low).
Nevertheless, looking at the number of tissue-specific SNVs and
their location, this pattern is different and it depends on the tissue
tested.
Mosaicism in humans has been widely reported [2,4,24–26] and
has been attributed to errors that occur during chromosome
segregation or DNA replication and that are transmitted to the
cellular lineage of the cell. Accordingly, some SNVs form at
different stages of development. Those formed in germlines will be
common to all cells of the organism; those generated during early
embryonic stages will be common to this lineage; and those
formed during late development or adulthood will be exclusive to a
cell type or group of cells. Given the number of lineages present in
a particular tissue, it is reasonable to assume that there will be
SNVs common to all the cells in the tissue, while others will be
shared by the same cell type or group of cells. Here we have used
highly sensitive DNA sequencing technique to detect genomic
variations. We propose that the higher the number of reads
covering a SNV, the greater the number of DNA molecules having
this variation and that these highly covered SNVs are formed early
in development. To illustrate this, we analyzed the GO terms for
molecular functions of genes containing highly covered SNVs
(equal or more than 100 reads per SNV) in the hippocampus and
blood. We observed an enrichment in GO annotations related to
neural function in hippocampus-specific genes with highly covered
SNVs. In contrast, blood-specific genes showed enrichment in
other terms, these more related to metabolism.
The presence of tissue-specific SNVs, their particular distribu-
tion along the chromosomes, and the molecular function of genes
with a higher coverage per SNV support the idea of mosaicism in
tissues and the relationship between the type and number of SNVs
and tissue cellular lineage.
In the second part, we analyzed unique SNVs in 16 tissues (of
diverse embryonic origin) from the same individual. The
comparison between tissues showed a different number and
distribution of unique SNVs along the chromosomes when they
were confronted between them by pairwise comparison. No clear
relationship between the number of unique SNVs and the
embryonic origin of the tissues, when compared against the rest
by pairwise comparison, was detected. However, some differences
were detected in the number of total SNVs per chromosome in
tissues of distinct embryonic origin, while those from the same
embryonic layer showed a similar SNV pattern and distribution
along the chromosomes. The differences between tissues were
specially marked in some particular chromosomes, mainly in 19,
17 and 16, thus supporting the notion that SNVs are more likely to
form at certain locations.
At present, the results reported here can be obtained only with
the method described. Future sequencing techniques may show
increased sensitivity to detect SNVs present in a minority of cells in
a tissue. In this regard, ‘‘traditional’’ methods, based on Sanger
sequencing techniques, have the handicap that they are designed
to sequence homogeneous samples. While recently reported
methods of single-cell sequencing are promising for the detection
of individual variations in a single cell, they are not fully
developed, and the extensive PCR-based amplification used in
this method might interfere with the resolution of this approach
[27]. However, it should be tested whether new digital PCR
techniques that could be now available, may solve this issue [28].
In summary, here we found tissue-specific differences in SNVs
after testing 16 tissue types. The distribution of SNVs on the
chromosomes indicates a specific signature for each tissue. The
differences were found to be higher when comparing tissues of
distinct embryonic origin.
Supporting Information
Figures S1 Distribution along all the chromosomes of tissue-
specific SNVs. Histograms showing the number of unique SNVs
for all the chromosomes on the basis of tissue type. Each blue bar
shows the number of tissue-specific SNVs per million of base pairs
for the chromosomes in the Frontal Cortex but not in the
spinal cord (FC-SC, S1).
(TIF)
Figure S2 Distribution along all the chromosomes of tissue-
specific SNVs. Histograms showing the number of unique SNVs
for all the chromosomes on the basis of tissue type. Each blue bar
shows the number of tissue-specific SNVs per million of base pairs
for the chromosomes in the spinal cord but not in the
Frontal Cortex (SC_FC, S2).
(TIF)
Figure S3 Distribution along all the chromosomes of tissue-
specific SNVs. Histograms showing the number of unique SNVs
for all the chromosomes on the basis of tissue type. Each blue bar
shows the number of tissue-specific SNVs per million of base pairs
for the chromosomes in the Frontal Cortex but not in blood
(FC_B, S3).
(TIF)
Figure S4 Distribution along all the chromosomes of tissue-
specific SNVs. Histograms showing the number of unique SNVs
for all the chromosomes on the basis of tissue type. Each blue bar
shows the number of tissue-specific SNVs per million of base pairs
for the chromosomes in blood but not in the Frontal Cortex
(B_FC, S4).
(TIF)
Figure S5 Distribution along all the chromosomes of tissue-
specific SNVs. Histograms showing the number of unique SNVs
for all the chromosomes on the basis of tissue type. Each blue bar
shows the number of tissue-specific SNVs per million of base pairs
for the chromosomes in the Frontal Cortex but not in
pancreas (FC_Pa, S5).
(TIF)
Figure S6 Distribution along all the chromosomes of tissue-
specific SNVs. Histograms showing the number of unique SNVs
for all the chromosomes on the basis of tissue type. Each blue bar
shows the number of tissue-specific SNVs per million of base pairs
for the chromosomes and in pancreas but not in the Frontal
Cortex (Pa_FC, S6).
(TIF)
File S1 Tables containing all tissue-specific SNVs from individ-
ual C.
(XLS)
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